Phase 1/2 Safety and Efficacy Study of AAV-RPE65 Vector to Treat Leber Congenital Amaurosis

Clinical trial NCT00749957 · COMPLETED

Trial details

NCT number: NCT00749957
Sponsor: Beacon Therapeutics
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Leber Congenital Amaurosis

Start date: 2009-06-17
Primary completion: 2014-09-23
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.